Evaluation of Compression Garments as Countermeasures to Orthostatic Intolerance

Previous work in our laboratory demonstrated that the NASA Anti-Gravity Suit and the Russian Kentavr compression garment were effective countermeasures to orthostatic intolerance in subjects whose plasma volume was reduced pharmacologically to a similar degree as experienced by astronauts. While these compression garments were effective in these conditions, two observations led to the evaluation of other compression garments/conditions. First, although the AGS and Kentavr appeared to be equally effective in the initial study, the level of compression provided by the two garments were very different. The Kentavr provided compression of ~30 mmHg but the AGS was inflated to a pressure of ~78 mmHg. Thus, one objective of this study was to determine whether the AGS could provide a similar level of protection as the Kentavr when the AGS was inflated to provide a similar level of compression (~26 mmHg). Second, astronauts have reported uncomfortable levels of abdominal compression while using the AGS, which may be particularly problematic after completing the pre-landing fluid loading protocol. Therefore, the second objective of this study was to determine the efficacy of a thigh-high compression garment, which might be more effective than either the AGS or the Kentavr because it provided a gradient compression to promote venous return. Both the AGS and Kentavr apply approximately the same level of compression across the entire length of the garment, but a commercially-available garment provides the highest pressure at the ankle, and the pressure decreases up the leg to the top of the thigh. Both garments were evaluated in normal healthy subjects who were hypovolemic due to the infusion of furosemide (Lasix), as has been previously used in our laboratory. The specific aims of this study were: 1. Evaluate the effectiveness of thigh-high compression garments to prevent orthostatic intolerance in hypovolemic subjects. 2. Evaluate the effectiveness of the Anti-Gravity Suit (AGS) at 1 “click” (0.5 psi) to prevent orthostatic intolerance in hypovolemic subjects. 3. Compare the effectiveness of the two garments which provide similar average levels of compression across their respective lengths but provide different levels of coverage (thigh-high vs. abdomen-high).

Differences in the level of protection despite similar average levels of compression provided by the two garments suggest that differences in the amount of coverage of the two garments (thigh-high compression garments vs. abdomen-high AGS) tested in this study is a key factor in the design of orthostatic intolerance countermeasure garments.

This is early/mid-stage (TRL 5) — the most realistic path in is NASA SBIR/STTR, which funds small businesses and research institutions to develop technology aligned with NASA's needs (equity-free, phased funding). Check whether a current SBIR/STTR solicitation topic overlaps with this project's technology area, or contact the project directly (above) to ask.

None of these are guaranteed paths for this specific project — TechPort itself doesn't have an "apply" button. Reaching out to the contact(s) above with a specific question is usually the fastest way to find out what's actually open.